[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Page 69086]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-10DE]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC), Agency for
Toxic Substances and Disease Registry (ATSDR) publishes a list of
information collection requests under review by the Office of
management and Budget (OMB) in compliance with the Paperwork Reduction
Act (33 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer, at (404) 639-5960 or send an e-mail
to [email protected]. Send written comments to ATSDR Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Creation of State and Metropolitan Area-based Surveillance Projects
for Amyotrophic Lateral Sclerosis (ALS)--New--Agency for Toxic
Substances and Disease Registry (ATSDR).
Background and Brief Description
On October 10, 2008, President Bush signed S. 1382: ALS Registry
Act which amended the Public Health Service Act to provide for the
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The
activities described are part of the effort to create the National ALS
Registry. The purpose of the registry is to: (1) Better describe the
incidence and prevalence of ALS in the United States; (2) examine
appropriate factors, such as environmental and occupational, that might
be associated with the disease; (3) better outline key demographic
factors (such as age, race or ethnicity, gender, and family history of
individuals diagnosed with the disease); and (4) better examine the
connection between ALS and other motor neuron disorders that can be
confused with ALS, misdiagnosed as ALS, and in some cases progress to
ALS. The registry will collect personal health information that may
provide a basis for further scientific studies of potential risks for
developing ALS.
This project purposes to collect information-specific data related
to ALS. The objective of this project is to develop state-based and
metropolitan area-based surveillance projects for ALS. The primary goal
of the state-based and metropolitan area-based surveillance project is
to use these data to evaluate the completeness of the National ALS
Registry. The secondary goal of the surveillance project is to obtain
reliable and timely information on the incidence and prevalence of ALS
and to better describe the demographic characteristics (e.g., age,
race, sex, and geographic location) of those with ALS.
Neurologists or their staff will complete an ALS Case Reporting
Form on each of their ALS patients. This will be transmitted to the
state or metropolitan health department. The contract surveillance
staff assigned to the state and metropolitan area health departments
will train medical personnel how to complete the ALS Case Reporting
Form (Attachment 3) and assist with abstracting records as requested.
An ALS Medical Record Verification Form will be collected on a subset
of cases reported. Each medical provider reporting source should keep a
line listing of individuals diagnosed with or thought to have ALS along
with information on whether or not the case was reported and if not,
the reason. Surveillance items to be collected include information to
make sure that there are no duplicates. There are no costs to the
respondents other than their time. The estimated annualized burden
hours are 703.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of data collection instrument Type of respondent respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Training.............................. Medical Personnel/ 243 1 30/60
Neurologist.
ALS Case Reporting Form............... Medical Personnel/ 2,250 1 5/60
Neurologist.
ALS Medical Record Verification Form.. Neurologist............. 450 1 20/60
Line Listing (record keeping)......... Medical Personnel....... 243 1 1
----------------------------------------------------------------------------------------------------------------
Dated: November 4, 2010.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention/Agency for Toxic Substances and Disease Registry.
[FR Doc. 2010-28337 Filed 11-9-10; 8:45 am]
BILLING CODE P